In the last 12 months, insiders at Jasper Therapeutics, Inc. ($JSPR) filed 55 transactions with the SEC: 9 open-market purchases totaling $4,879,990 and 4 sales totaling $84,534. Net insider sentiment: net buying.
Jasper Therapeutics, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Velan Capital Investment Management LP (TenPercentOwner) — 1 transaction totaling $4,532,500
- Mahal Jeetinder Singh (Chief Operating Officer) — 16 transactions totaling $110,094
- Shizuru Judith Anne (Director) — 4 transactions totaling $99,630
- WIGGANS THOMAS G (Director) — 4 transactions totaling $99,630
- MARTELL RON (President and CEO) — 3 transactions totaling $99,630
View all SEC Filings for Jasper Therapeutics, Inc. (JSPR).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 6, 2026 | Mahal Jeetinder Singh | CEO and President | A | Stock Option (right to buy) | 500000 | $0.00 | 500,000.0000 | 16,635,784 | 9999.99% | 3.01% |
| Jan. 2, 2026 | CROSS HERB | Chief Financial Officer | A | Stock Option (right to buy) | 90000 | $0.00 | 90,000.0000 | 16,635,784 | 9999.99% | 0.54% |
| Jan. 2, 2026 | Mahal Jeetinder Singh | Chief Operating Officer | A | Stock Option (right to buy) | 90000 | $0.00 | 90,000.0000 | 16,635,784 | 9999.99% | 0.54% |
| Jan. 2, 2026 | MARTELL RON | President, CEO and Director | A | Stock Option (right to buy) | 234000 | $0.00 | 234,000.0000 | 16,635,784 | 9999.99% | 1.41% |
| Sept. 22, 2025 | Lucas Svetlana | Director | P | Voting Common Stock | 20000 | $2.43 | 20,000.0000 | 15,333,962 | 9999.99% | 0.13% |
| Sept. 22, 2025 | WIGGANS THOMAS G | Director | P | Common Stock Warrant (right to buy) | 41000 | $0.00 | 41,000.0000 | 15,333,962 | 9999.99% | 0.27% |
| Sept. 22, 2025 | WIGGANS THOMAS G | Director | P | Voting Common Stock | 41000 | $2.43 | 46,000.0000 | 15,333,962 | 820.00% | 0.27% |
| Sept. 22, 2025 | Shizuru Judith Anne | Director | P | Voting Common Stock | 41000 | $2.43 | 156,901.0000 | 15,333,962 | 35.38% | 0.27% |
| Sept. 22, 2025 | Shizuru Judith Anne | Director | P | Common Stock Warrant (right to buy) | 41000 | $0.00 | 41,000.0000 | 15,333,962 | 9999.99% | 0.27% |
| Sept. 22, 2025 | MARTELL RON | President and CEO | P | Common Stock Warrant (right to buy) | 41000 | $0.00 | 41,000.0000 | 15,333,962 | 9999.99% | 0.27% |
| Sept. 22, 2025 | MARTELL RON | President and CEO | P | Voting Common Stock | 41000 | $2.43 | 74,118.0000 | 15,333,962 | 123.80% | 0.27% |
| Sept. 22, 2025 | Lucas Svetlana | Director | P | Common Stock Warrant (right to buy) | 20000 | $0.00 | 20,000.0000 | 15,333,962 | 9999.99% | 0.13% |
| July 3, 2025 | Brun Scott C. | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 15,333,962 | 9999.99% | 0.05% |
| July 3, 2025 | EMSTER KURT VON | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 15,333,962 | 9999.99% | 0.05% |
| July 3, 2025 | Shizuru Judith Anne | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 15,333,962 | 9999.99% | 0.05% |
| July 3, 2025 | Nolet Chris | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 15,333,962 | 9999.99% | 0.05% |
| July 3, 2025 | Kapoor Vishal | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 15,333,962 | 9999.99% | 0.05% |
| July 3, 2025 | WIGGANS THOMAS G | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 15,333,962 | 9999.99% | 0.05% |
| July 3, 2025 | Lucas Svetlana | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 15,333,962 | 9999.99% | 0.05% |
| June 4, 2025 | CROSS HERB | Chief Financial Officer | A | Stock Option (right to buy) | 90000 | $0.00 | 90,000.0000 | 15,022,122 | 9999.99% | 0.60% |
| June 4, 2025 | Tucker Edwin Jonathan | Chief Medical Officer | A | Stock Option (right to buy) | 90000 | $0.00 | 90,000.0000 | 15,022,122 | 9999.99% | 0.60% |
| June 4, 2025 | MARTELL RON | President and CEO | A | Stock Option (right to buy) | 234000 | $0.00 | 234,000.0000 | 15,022,122 | 9999.99% | 1.56% |
| June 4, 2025 | Mahal Jeetinder Singh | Chief Operating Officer | A | Stock Option (right to buy) | 90000 | $0.00 | 90,000.0000 | 15,022,122 | 9999.99% | 0.60% |
| Feb. 13, 2025 | MARTELL RON | President, CEO and Director | A | Stock Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 14,584,870 | 9999.99% | 0.89% |
| Feb. 13, 2025 | Tucker Edwin Jonathan | Chief Medical Officer | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 14,584,870 | 9999.99% | 0.34% |
| Feb. 13, 2025 | Mahal Jeetinder Singh | Chief Operating Officer | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 14,584,870 | 9999.99% | 0.34% |
| Feb. 13, 2025 | CROSS HERB | Chief Financial Officer | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 14,584,870 | 9999.99% | 0.34% |
| Dec. 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | M | Voting Common Stock | 900 | $7.10 | 25,909.0000 | 15,000,516 | 3.60% | 0.01% |
| Dec. 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | M | Stock Option (right to buy) | 900 | $0.00 | 13,772.0000 | 15,000,516 | 6.99% | 0.01% |
| Dec. 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | S | Voting Common Stock | 900 | $22.11 | 25,009.0000 | 15,000,516 | 3.47% | 0.01% |
| Sept. 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | S | Voting Common Stock | 900 | $21.23 | 25,009.0000 | 14,986,367 | 3.47% | 0.01% |
| Sept. 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | M | Stock Option (right to buy) | 900 | $0.00 | 14,672.0000 | 14,986,367 | 6.53% | 0.01% |
| Sept. 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | M | Voting Common Stock | 900 | $7.10 | 25,909.0000 | 14,986,367 | 3.60% | 0.01% |
| June 18, 2024 | Lucas Svetlana | Director | A | Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 13,334,900 | 9999.99% | 0.11% |
| June 10, 2024 | MARTELL RON | President, CEO and Director | A | Performance Restricted Stock Units | 20000 | $0.00 | 20,000.0000 | 13,334,900 | 9999.99% | 0.15% |
| June 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | M | Voting Common Stock | 900 | $7.10 | 25,909.0000 | 13,334,900 | 3.60% | 0.01% |
| June 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | S | Voting Common Stock | 900 | $24.16 | 25,009.0000 | 13,334,900 | 3.47% | 0.01% |
| June 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | M | Stock Option (right to buy) | 900 | $0.00 | 15,572.0000 | 13,334,900 | 6.13% | 0.01% |
| June 10, 2024 | MARTELL RON | President, CEO and Director | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 13,334,900 | 9999.99% | 0.07% |
| June 6, 2024 | WIGGANS THOMAS G | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 13,334,900 | 9999.99% | 0.06% |
| June 6, 2024 | EMSTER KURT VON | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 13,334,900 | 9999.99% | 0.06% |
| June 6, 2024 | Kapoor Vishal | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 13,334,900 | 9999.99% | 0.06% |
| June 6, 2024 | Shizuru Judith Anne | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 13,334,900 | 9999.99% | 0.06% |
| June 6, 2024 | Nolet Chris | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 13,334,900 | 9999.99% | 0.06% |
| June 6, 2024 | French Anna Louise | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 13,334,900 | 9999.99% | 0.06% |
| June 7, 2024 | Tucker Edwin Jonathan | Chief Medical Officer | A | Voting Common Stock | 400 | $4.17 | 400.0000 | 13,334,900 | 9999.99% | 0.00% |
| June 6, 2024 | Brun Scott C. | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 13,334,900 | 9999.99% | 0.06% |
| March 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | S | Voting Common Stock | 900 | $26.44 | 25,009.0000 | 10,439,034 | 3.47% | 0.01% |
| March 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | M | Voting Common Stock | 900 | $7.10 | 25,909.0000 | 10,439,034 | 3.60% | 0.01% |
| March 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | M | Stock Option (right to buy) | 900 | $0.00 | 16,472.0000 | 10,439,034 | 5.78% | 0.01% |
| Feb. 15, 2024 | CROSS HERB | Chief Financial Officer | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 10,439,034 | 9999.99% | 0.38% |
| Feb. 15, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 10,439,034 | 9999.99% | 0.38% |
| Feb. 15, 2024 | MARTELL RON | President, CEO and Director | A | Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 10,439,034 | 9999.99% | 0.96% |
| Feb. 15, 2024 | Tucker Edwin Jonathan | Chief Medical Officer | A | Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 10,439,034 | 9999.99% | 0.43% |
| Feb. 8, 2024 | Velan Capital Investment Management LP | TenPercentOwner | P | Common Stock, par value $0.0001 per share | 350000 | $12.95 | 1,433,828.0000 | 10,439,034 | 32.29% | 3.35% |